UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004061
Receipt No. R000004867
Scientific Title A phase II study of Bortezomib for relapsed/refractory adult T-cell leukemia/lymphoma (ATL)
Date of disclosure of the study information 2010/08/18
Last modified on 2017/10/03 21:52:44

No. Disposal Last modified on Item of update
1 Insert 2010/08/18 11:51:07
2 Update 2011/09/27 15:47:54 Organization
Organization
Category of Funding Organization
Name of secondary funder(s)
Name of secondary funder(s)
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2012/02/18 15:05:02 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
4 Update 2012/03/22 10:55:01


5 Update 2012/03/22 10:56:46 Institutions
6 Update 2012/03/22 10:58:08 Organization3
Address3
Tel3
Email3
7 Update 2013/02/13 23:06:20 Institutions
8 Update 2013/02/13 23:08:55 Last follow-up date
9 Update 2013/10/19 17:10:17 Email
Institutions
10 Update 2014/03/18 22:41:25 Recruitment status
Last follow-up date
11 Update 2015/02/18 11:46:48 Recruitment status
Last follow-up date
12 Update 2017/10/03 21:52:45 Publication of results
Results


Contact us.